Literature DB >> 28747069

A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC.

Toshiaki Iba1, Marcello Di Nisio2, Jecko Thachil3, Hideo Wada4, Hidesaku Asakura5, Koichi Sato6, Daizoh Saitoh7.   

Abstract

Sepsis-associated disseminated intravascular coagulation (DIC) carries a high risk of death. Thus, a simple tool to quickly establish DIC diagnosis is required. The purpose of this study was to introduce the simple and reliable tool for the prediction of outcome in patients with sepsis complicated by coagulopathy. We investigated the performance of simplified Japanese Society on Thrombosis and Hemostasis (JSTH) DIC diagnostic criteria. In this study, we conducted a retrospective, multicenter survey in 107 general emergency and critical care centers in secondary and tertiary care hospitals. A total of 918 patients with sepsis-associated coagulopathy who underwent antithrombin supplementation were examined. The relationships between patient mortality and each of the baseline (ie, before treatment) JSTH-DIC diagnostic criteria were examined. A reduced platelet count, increased prothrombin time (PT) ratio, and lower antithrombin activity were correlated with 28-day mortality, while fibrinogen and fibrin degradation product (FDP) level were not. Thus, the number of points assigned to FDP levels was reduced from 3 to 1 (above 20 μg/mL). The simplified JSTH diagnostic criteria combining platelet count, PT ratio, antithrombin activity, and FDP level (reduction in the maximum score) strongly predicted 28-day mortality and allowed us to diagnose a larger/similar number of patients with DIC as compared to the original JSTH-DIC. The simplified JSTH-DIC diagnostic criteria show a similar performance to JSTH-DIC criteria in patients with septic coagulopathy. The lower number of laboratory markers used in the simplified JSTH-DIC score may increase its applicability and routine use in emergency and critical care setting.

Entities:  

Keywords:  antithrombin activity; diagnostic criteria; disseminated intravascular coagulation; fibrinogen and fibrin degradation products; sepsis

Mesh:

Substances:

Year:  2017        PMID: 28747069      PMCID: PMC6714647          DOI: 10.1177/1076029617720069

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  34 in total

Review 1.  Disseminated intravascular coagulation: clinical spectrum and established as well as new diagnostic approaches.

Authors:  G Müller-Berghaus; H ten Cate; M Levi
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

2.  Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

Authors:  F B Taylor; C H Toh; W K Hoots; H Wada; M Levi
Journal:  Thromb Haemost       Date:  2001-11       Impact factor: 5.249

Review 3.  Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis.

Authors:  Laurent O Mosnier; Bonno N Bouma
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-09-07       Impact factor: 8.311

4.  High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety.

Authors:  Christian J Wiedermann; Johannes N Hoffmann; Mathias Juers; Helmut Ostermann; Joachim Kienast; Josef Briegel; Richard Strauss; Heinz-Otto Keinecke; Brian L Warren; Steven M Opal
Journal:  Crit Care Med       Date:  2006-02       Impact factor: 7.598

Review 5.  The role of natural anticoagulants in the pathogenesis and management of systemic activation of coagulation and inflammation in critically ill patients.

Authors:  Marcel Levi; Tom van der Poll
Journal:  Semin Thromb Hemost       Date:  2008-10-27       Impact factor: 4.180

6.  Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies.

Authors:  F Fourrier; C Chopin; J Goudemand; S Hendrycx; C Caron; A Rime; A Marey; P Lestavel
Journal:  Chest       Date:  1992-03       Impact factor: 9.410

7.  Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey.

Authors:  Satoshi Gando; Daizoh Saitoh; Hiroshi Ogura; Toshihiko Mayumi; Kazuhide Koseki; Toshiaki Ikeda; Hiroyasu Ishikura; Toshiaki Iba; Masashi Ueyama; Yutaka Eguchi; Yasuhiro Ohtomo; Kohji Okamoto; Shigeki Kushimoto; Shigeatsu Endo; Shuji Shimazaki
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

8.  Disseminated intravascular coagulation (DIC) diagnosed based on the Japanese Association for Acute Medicine criteria is a dependent continuum to overt DIC in patients with sepsis.

Authors:  Satoshi Gando; Daizoh Saitoh; Hiroshi Ogura; Toshihiko Mayumi; Kazuhide Koseki; Toshiaki Ikeda; Hiroyasu Ishikura; Toshiaki Iba; Masashi Ueyama; Yutaka Eguchi; Yasuhiro Otomo; Kohji Okamoto; Shigeki Kushimoto; Shigeatsu Endo; Shuji Shimazaki
Journal:  Thromb Res       Date:  2008-09-05       Impact factor: 3.944

9.  A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria.

Authors:  Satoshi Gando; Toshiaki Iba; Yutaka Eguchi; Yasuhiro Ohtomo; Kohji Okamoto; Kazuhide Koseki; Toshihiko Mayumi; Atsuo Murata; Toshiaki Ikeda; Hiroyasu Ishikura; Masashi Ueyama; Hiroshi Ogura; Shigeki Kushimoto; Daizoh Saitoh; Shigeatsu Endo; Shuji Shimazaki
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

Review 10.  Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis.

Authors:  Steven M Opal; Charles T Esmon
Journal:  Crit Care       Date:  2002-12-20       Impact factor: 9.097

View more
  11 in total

1.  Clinical Efficacy of Soluble Thrombomodulin, Tissue Plasminogen Activator Inhibitor complex, Thrombin-Antithrombin complex,α2-Plasmininhibitor-Plasmin complex in Pediatric Sepsis.

Authors:  Juanzhen Li; Jingyi Zhou; Hong Ren; Teng Teng; Biru Li; Ying Wang; Long Xiang
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

2.  Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients.

Authors:  Yu Zuo; Mark Warnock; Alyssa Harbaugh; Srilakshmi Yalavarthi; Kelsey Gockman; Melanie Zuo; Jacqueline A Madison; Jason S Knight; Yogendra Kanthi; Daniel A Lawrence
Journal:  Sci Rep       Date:  2021-01-15       Impact factor: 4.379

3.  [Treatment of sepsis-induced coagulopathy : Results of a Germany-wide survey in intensive care units].

Authors:  Thomas Schmoch; Thorsten Brenner; Andrea Becker-Pennrich; Ludwig Christian Hinske; Markus A Weigand; Josef Briegel; Patrick Möhnle
Journal:  Anaesthesist       Date:  2021-02-08       Impact factor: 1.041

4.  Consumptive coagulopathy is associated with a disturbed host response in patients with sepsis.

Authors:  Lonneke A van Vught; Fabrice Uhel; Chao Ding; Cees Van't Veer; Brendon P Scicluna; Hessel Peters-Sengers; Peter M C Klein Klouwenberg; Peter Nürnberg; Olaf L Cremer; Marcus J Schultz; Tom van der Poll
Journal:  J Thromb Haemost       Date:  2021-02-17       Impact factor: 5.824

5.  Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19.

Authors:  Yu Zuo; Shanea K Estes; Ramadan A Ali; Alex A Gandhi; Srilakshmi Yalavarthi; Hui Shi; Gautam Sule; Kelsey Gockman; Jacqueline A Madison; Melanie Zuo; Vinita Yadav; Jintao Wang; Wrenn Woodard; Sean P Lezak; Njira L Lugogo; Stephanie A Smith; James H Morrissey; Yogendra Kanthi; Jason S Knight
Journal:  Sci Transl Med       Date:  2020-11-02       Impact factor: 17.956

Review 6.  The Cause-Effect Dilemma of Hematologic Changes in COVID-19: One Year after the Start of the Pandemic.

Authors:  Ilham Youssry; Dalia Abd Elaziz; Nardeen Ayad; Iman Eyada
Journal:  Hematol Rep       Date:  2022-03-28

7.  Pathogenic factors associated with development of disseminated intravascular coagulopathy (DIC) in a tertiary academic hospital in South Africa.

Authors:  Elizabeth S Mayne; Anthony L H Mayne; Susan J Louw
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

8.  [Progress in quantitative diagnosis of sepsis-induced disseminated intravascular coagulation].

Authors:  L L Luo; H Mei; Y Hu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-05-14

9.  Prevalence and Impact of Coagulation Dysfunction in COVID-19 in China: A Meta-Analysis.

Authors:  Shanen Jin; Yiyang Jin; Bai Xu; Jun Hong; Xianghong Yang
Journal:  Thromb Haemost       Date:  2020-07-17       Impact factor: 5.249

Review 10.  Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review.

Authors:  Francesco Nappi; Omar Giacinto; Omar Ellouze; Antonio Nenna; Sanjeet Singh Avtaar Singh; Massimo Chello; Assine Bouzguenda; Xavier Copie
Journal:  Biomedicines       Date:  2022-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.